Angus Chen

Miriam Merad’s 20-year quest to understand one cell is starting to rewrite the rules of cancer immunotherapy.

The potential reasons that a Covid vaccine would help treat cancer are intriguing.

A popular and respected scientist is reported to be in line to lead the nation's most important cancer research office.

Federal workers send Congress a letter pleading for help, but their trouble attracting signatures reflects fear of retaliation.

A new liquid biopsy test from Exact Sciences scans for 50 cancers in one blood sample. The company says it marks a new era in early detection, but there are caveats.

“It’s shocking. We haven’t had an advance in this space for maybe ever,” an oncologist said about a new use of proton beam radiation.

As mRNA falls out of favor for HHS, are cancer vaccines next?

Screening guideline change led to more colorectal cancers being detected early in younger adults

The order applies to the entirety of new and, possibly, ongoing research grant dollars that go to universities and academic medical centers.

NIH plans to shrink the share of grant applications it will award for the remainder of the fiscal year, in some cases by more than half.

Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the “flare” antigen — on every cancer cell in a patient's body.

Robert F. Kennedy Jr. just named Mark Cruz, a Klamath member, his top tribal health adviser. In a Q&A, Cruz emphasized tribal control of health facilities.

Numerous service and staffing cuts at IHS facilities nationally have been caused by a new HHS contract review process, according to IHS workers and emails.

The SCOTUS decision preserves free preventive health care and sets the stage for a bigger role for RFK Jr. in determining what's covered.

Liquid biopsy tests are growing in use and showing promise in cancer detection, but experts say more trials are needed on the clinical benefit of ctDNA testing.

ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new study.

Like a Las Vegas buffet, ASCO offers a diverse bounty of clinical data.

Scientists see a worrying rise in late-stage prostate cancer diagnoses. Experts say prostate cancer screening, once seen as controversial, is beneficial.

Health insurers continue to use algorithms to predict how long patients need intense care — and thus how much care is covered, an attorney says. #STATBreakthrough